Marshall Wace
COYA icon

Marshall Wace’s Coya Therapeutics COYA Stock Holding History

Marshall Wace’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$890K Buy
225,792
+434
+0.2% +$2.03K ﹤0.01% 2194
2025
Q4 		$1.31M Buy
225,358
+183,533
+439% +$1.12M ﹤0.01% 1794
2025
Q3 		$238K Buy
+41,825
New +$254K ﹤0.01% 2519

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace's COYA Position: Q1 2026 in Review

Marshall Wace increased its Coya Therapeutics (COYA) stake by 0.19% in Q1 2026, buying an estimated $2.03K and bringing the position to 225,792 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Marshall Wace first reported a position in COYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.31M in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Marshall Wace held 225,792 shares of Coya Therapeutics worth $890K as of Q1 2026.
  • Marshall Wace bought 434 Coya Therapeutics shares in Q1 2026, an estimated $2.03K.
  • Coya Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2194 holding.
  • Marshall Wace first reported a position in Coya Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Marshall Wace's Coya Therapeutics position peaked at $1.31M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.